Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.74
+0.22 (3.99%)
At close: Mar 10, 2026, 4:00 PM EDT
5.76
+0.02 (0.35%)
Pre-market: Mar 11, 2026, 5:22 AM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $287.21 million as of March 11, 2026. Its market cap has increased by 51.53% in one year.
Market Cap
287.21M
Enterprise Value
92.08M
1-Year Change
51.53%
Ranking
Category
Stock Price
$5.74
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $287.21M, an increase of 215.28%. That is a compound annual growth rate of 24.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 287.21M | -29.64% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 292.38M |
| Coherus Oncology | 288.48M |
| AC Immune | 282.98M |
| OmniAb | 282.33M |
| ALX Oncology Holdings | 281.42M |
| Abeona Therapeutics | 279.63M |
| Ovid Therapeutics | 278.59M |
| Enlivex | 275.36M |